CEO, Chief Science Officer and Co-Founder
Jeanette is a microbiologist and immunologist with over fifteen years experience. She is a prolific inventor who holds patents in the areas of microbial strain selection and immunology, as well as numerous provisional patents and trade secrets. She has a BS in Biology from the University of Miami. Jeanette is also a 19 time Ironman distance triathlon finisher, including the 2009 World Championship.
Anthony Cann, PhD
Chief Technology Officer and Co-Founder
Dr. Cann has over fourteen years of experience in strain improvement with expertise in microbial metabolism. Anthony has conducted several successful technology transfers around the globe, from test tube to large scale fermentations. He earned a PhD in Chemical Engineering from UCLA, a BS in Chemical Engineering from Rose-Hulman Institute of Technology, and he co-authored several patent applications in the fields of strain development and biochemical production.
Chief Operations Officer and Co-Founder
Derik is a microbiologist and fermentation specialist with over ten years industrial experience. He is very versatile in the multidisciplinary environment of a startup; having contributed to biomass pre-treatment, microbiology, and scale-up fermentation R&D areas within the cleantech industry. Derik holds a BS in Cell & Developmental Biology from the University of California at Santa Barbara.
Maya Kuttan, Esq.
Chief Counsel and Media Specialist
Maya has over nine years of experience as an attorney and fifteen years as a media specialist. She has provided regulatory counseling, enforcement, litigation support, and rulemaking for the U.S. Environmental Protection Agency and municipalities, agencies, and nonprofits. She earned a JD from the University of California, Los Angeles (UCLA) School of Law and a BA from the University of Southern California’s School of Cinematic Arts. Maya has garnered awards for her films and legal work.
Stacy Townsend, PhD
Director of Pre-Clinical Development
Dr. Townsend has over fifteen years of research and preclinical development experience with expertise in host-pathogen interactions supporting biotechnology with a broad range of therapeutic indications. Stacy has successfully led R&D efforts resulting in numerous patents, grants, and IND submissions. She earned her PhD in Veterinary Microbiology from Texas A&M University, a BS from the University of California, Riverside.
Gregory R. Govoni, PhD
Director of Pre-Clinical Research
Dr. Govoni has over twenty years of experience in the microbiology and immunology fields with 5 years as a project lead at a local Bay Area startup developing novel anti-bacterial agents. He earned his PhD degree in Biochemistry from McGill University and completed a post-doctoral fellowship in Microbiology and Immunology with Dr. Stanley Falkow at Stanford University. He has co-authored 20 peer-reviewed scientific publications as well as been named co-inventor on multiple patents.
Parva Zarei, PhD
Dr. Zareitalabad has many years of experience in microbiology and has an expertise in international soil pharmacology. She accomplished her postdoc in soil microbiology and biotechnology at University of California Santa Cruz and earned her PhD in agricultural engineering at University of Bonn and her M.S. in ecological agriculture at University of Kassel in Germany.
Igor Gonda, PhD
Drug Development Consultant
Dr. Gonda is an expert in pulmonary drug development, with decades of achievements in pharmaceuticals and academia. Recently CEO of Aradigm, a company focused on drug development for severe respiratory diseases, while at Genentech Dr. Gonda was responsible for the inhalation development of Pulmozyme - recombinant human DNase used in the management of the orphan disease cystic fibrosis. Dr. Gonda has held academic positions at the University of Aston and the University of Sydney. Dr. Gonda has a B.Sc. in Chemistry and a Ph.D. in Physical Chemistry from Leeds University, UK.
Dr. Patrick Flume, MD
Leading expert on clinical programs for cystic fibrosis and NTM. Endowed Chair for Cystic Fibrosis at the Medical University of
Dr. Julian Davies, PhD
The pioneer of metagenomics, 60 yrs in microbiology, infectious disease expert. Professor Emeritus at Life Sciences Institute at the University of British Columbia.
Dr. Peter Dürre, PhD
A leading expert in Clostridium difficile and gene transfer technology. Head of Microbiology and Biotechnology Departments at Ulm University.
Dr. John LiPuma, MD
The leading expert on lung microbiology in cystic fibrosis, this pediatric infectious disease doctor has spent over 30yrs in clinical research.
Dr. Annalisa Jenkins, MRCP, FRCP
20yrs industry experience, CEO Dimension Therapeutics, former head of Global Research and Development for Merck Serono.
Dr. Mark Wilcox, MD
Lead on Clostridium difficile for the Public Health England, he's an expert on Antimicrobial Resistance and Infection Control. Head of Microbiology and Pathology at the University of Leeds.